
|Articles|February 2, 2022
Pharmacy Clinical Pearl of the Day: Granulomatosis
Author(s)Saro Arakelians, PharmD
Granulomatosis is among a group of blood vessel disorders called vasculitis.
Advertisement
Clinical Pearl of the Day: Granulomatosis
Granulomatosis with polyangiitis is an uncommon disorder that causes inflammation of the blood vessels in your nose, sinuses, throat, lungs, and kidneys.
Insight:
- Formerly called Wegener's granulomatosis, this condition is one of a group of blood vessel disorders called vasculitis.
- Granulomatosis slows blood flow to some organs. The affected tissues can develop areas of inflammation called granulomas, which can affect how these organs work.
- Symptoms may includepus-like drainage with crusts from the nose, stuffiness, sinus infections, nosebleeds, coughing, sometimes with bloody phlegm, shortness of breath or wheezing, fever, and joint pain.
- The cause of granulomatosis with polyangiitis isn't known. It's not contagious, and there's no evidence that it's inherited.
- Diagnosis may include lab tests, imaging studies, and biopsy.
- Medications to treat may include corticosteroids, cyclophosphamide, azathioprine (Azasan, Imuran), mycophenolate (CellCept), methotrexate (Trexall), and rituximab (Rituxan).
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Early RSV Vaccine Uptake Among Older Adults Reveals Significant Access Gaps
4
High Burden of PCV21 Strains in Norway Shows Need for Effective US Vaccination Strategies
5





































































































































































































